AUPH vs. AZN
Compare and contrast key facts about Aurinia Pharmaceuticals Inc. (AUPH) and AstraZeneca PLC (AZN).
Performance
AUPH vs. AZN - Performance Comparison
Loading graphics...
AUPH vs. AZN - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
AUPH Aurinia Pharmaceuticals Inc. | -7.08% | 77.62% | -0.11% | 108.10% | -81.11% | 65.37% | -31.74% | 197.07% | 50.55% | 115.71% |
AZN AstraZeneca PLC | 9.51% | 43.30% | -0.62% | 1.44% | 19.14% | 19.66% | 3.12% | 35.68% | 13.86% | 33.10% |
Fundamentals
AUPH:
$2.06B
AZN:
$308.06B
AUPH:
$2.06
AZN:
$6.55
AUPH:
7.19
AZN:
30.10
AUPH:
0.00
AZN:
0.04
AUPH:
7.29
AZN:
5.24
AUPH:
3.54
AZN:
6.33
AUPH:
$283.06M
AZN:
$58.74B
AUPH:
$250.39M
AZN:
$48.11B
AUPH:
$109.83M
AZN:
$19.83B
Returns By Period
In the year-to-date period, AUPH achieves a -7.08% return, which is significantly lower than AZN's 9.51% return. Both investments have delivered pretty close results over the past 10 years, with AUPH having a 17.52% annualized return and AZN not far behind at 16.71%.
AUPH
- 1D
- 6.01%
- 1M
- 4.59%
- YTD
- -7.08%
- 6M
- 34.12%
- 1Y
- 84.33%
- 3Y*
- 10.58%
- 5Y*
- 2.44%
- 10Y*
- 17.52%
AZN
- 1D
- 1.72%
- 1M
- -5.39%
- YTD
- 9.51%
- 6M
- 31.22%
- 1Y
- 37.92%
- 3Y*
- 15.06%
- 5Y*
- 17.44%
- 10Y*
- 16.71%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AUPH vs. AZN — Risk / Return Rank
AUPH
AZN
AUPH vs. AZN - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Aurinia Pharmaceuticals Inc. (AUPH) and AstraZeneca PLC (AZN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| AUPH | AZN | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.87 | 1.40 | +0.47 |
Sortino ratioReturn per unit of downside risk | 2.51 | 2.07 | +0.44 |
Omega ratioGain probability vs. loss probability | 1.36 | 1.27 | +0.09 |
Calmar ratioReturn relative to maximum drawdown | 4.95 | 3.20 | +1.75 |
Martin ratioReturn relative to average drawdown | 10.80 | 8.03 | +2.77 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| AUPH | AZN | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.87 | 1.40 | +0.47 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.04 | 0.74 | -0.70 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.24 | 0.67 | -0.44 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.16 | 0.51 | -0.34 |
Correlation
The correlation between AUPH and AZN is 0.16, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
AUPH vs. AZN - Dividend Comparison
AUPH has not paid dividends to shareholders, while AZN's dividend yield for the trailing twelve months is around 2.70%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AUPH Aurinia Pharmaceuticals Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
AZN AstraZeneca PLC | 2.70% | 1.70% | 2.27% | 2.15% | 2.12% | 2.35% | 2.80% | 2.81% | 3.69% | 3.95% | 5.01% | 4.06% |
Drawdowns
AUPH vs. AZN - Drawdown Comparison
The maximum AUPH drawdown since its inception was -87.58%, which is greater than AZN's maximum drawdown of -48.94%. Use the drawdown chart below to compare losses from any high point for AUPH and AZN.
Loading graphics...
Drawdown Indicators
| AUPH | AZN | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -87.58% | -48.94% | -38.64% |
Max Drawdown (1Y)Largest decline over 1 year | -15.91% | -12.24% | -3.67% |
Max Drawdown (5Y)Largest decline over 5 years | -87.58% | -27.87% | -59.71% |
Max Drawdown (10Y)Largest decline over 10 years | -87.58% | -27.87% | -59.71% |
Current DrawdownCurrent decline from peak | -55.20% | -5.39% | -49.81% |
Average DrawdownAverage peak-to-trough decline | -49.17% | -11.39% | -37.78% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.29% | 4.88% | +2.41% |
Volatility
AUPH vs. AZN - Volatility Comparison
Aurinia Pharmaceuticals Inc. (AUPH) has a higher volatility of 12.90% compared to AstraZeneca PLC (AZN) at 6.95%. This indicates that AUPH's price experiences larger fluctuations and is considered to be riskier than AZN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| AUPH | AZN | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.90% | 6.95% | +5.95% |
Volatility (6M)Calculated over the trailing 6-month period | 26.57% | 19.14% | +7.43% |
Volatility (1Y)Calculated over the trailing 1-year period | 45.34% | 27.28% | +18.06% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 68.68% | 23.83% | +44.85% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 74.42% | 24.90% | +49.52% |
Financials
AUPH vs. AZN - Financials Comparison
This section allows you to compare key financial metrics between Aurinia Pharmaceuticals Inc. and AstraZeneca PLC. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities